Sulfasalazine Market is Anticipated to Witness High Growth Owing to Increasing Number of IBD Cases The sulfasalazine market comprises oral medications containing sulfasalazine that are used to treat inflammatory bowel diseases (IBD) such as ulcerative colitis and some types of arthritis like rheumatoid arthritis. Sulfasalazine contains two components—sulfapyridine and 5-aminosalicylic acid. While sulfapyridine helps suppress the immune system, 5-aminosalicylic acid reduces inflammation...
0 Shares
567 Views
0 Reviews